CD8A and cancer: On the other hand, McGrail et al. [39] examined the relationship between TMB and the effectiveness of immune checkpoint blockade (ICB) therapy; their research indicated that in specific cancer types, including melanoma, lung, and bladder cancer, a positive correlation was observed between CD8 T-cell levels and neoantigen load [39].